Quilter Plc Acquires 48,282 Shares of Zoetis Inc. $ZTS

Quilter Plc lifted its holdings in Zoetis Inc. (NYSE:ZTS) by 11.0% in the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 487,241 shares of the company’s stock after acquiring an additional 48,282 shares during the quarter. Quilter Plc’s holdings in Zoetis were worth $61,305,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in ZTS. Diamond Hill Capital Management Inc. purchased a new stake in Zoetis during the third quarter valued at about $394,010,000. Nordea Investment Management AB lifted its stake in shares of Zoetis by 79.2% in the 4th quarter. Nordea Investment Management AB now owns 4,932,787 shares of the company’s stock valued at $622,222,000 after acquiring an additional 2,179,578 shares during the last quarter. Arrowstreet Capital Limited Partnership lifted its stake in shares of Zoetis by 83.4% in the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 2,697,827 shares of the company’s stock valued at $394,746,000 after acquiring an additional 1,227,085 shares during the last quarter. Corient Private Wealth LLC boosted its holdings in Zoetis by 85.9% during the 2nd quarter. Corient Private Wealth LLC now owns 2,578,593 shares of the company’s stock valued at $400,619,000 after acquiring an additional 1,191,840 shares during the period. Finally, First Trust Advisors LP grew its position in Zoetis by 342.1% during the 3rd quarter. First Trust Advisors LP now owns 1,485,459 shares of the company’s stock worth $217,352,000 after acquiring an additional 1,149,467 shares during the last quarter. Institutional investors own 92.80% of the company’s stock.

Analyst Ratings Changes

Several brokerages have weighed in on ZTS. BTIG Research reiterated a “buy” rating and issued a $160.00 price objective on shares of Zoetis in a research report on Thursday, February 26th. Leerink Partners restated a “market perform” rating on shares of Zoetis in a report on Tuesday, March 10th. Wall Street Zen raised shares of Zoetis from a “hold” rating to a “buy” rating in a research note on Saturday, February 21st. Weiss Ratings lowered shares of Zoetis from a “hold (c-)” rating to a “sell (d+)” rating in a report on Friday, March 27th. Finally, The Goldman Sachs Group raised shares of Zoetis to a “buy” rating in a report on Monday, December 15th. Six analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, Zoetis has a consensus rating of “Hold” and an average target price of $152.91.

Zoetis Stock Performance

Shares of ZTS stock opened at $117.83 on Monday. The firm has a market capitalization of $49.74 billion, a price-to-earnings ratio of 19.57, a PEG ratio of 1.80 and a beta of 0.98. The stock has a fifty day moving average of $122.71 and a 200 day moving average of $127.96. Zoetis Inc. has a 52 week low of $113.29 and a 52 week high of $172.23. The company has a quick ratio of 1.94, a current ratio of 3.03 and a debt-to-equity ratio of 2.71.

Zoetis (NYSE:ZTS) last issued its quarterly earnings data on Thursday, February 12th. The company reported $1.48 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.40 by $0.08. Zoetis had a net margin of 28.24% and a return on equity of 62.02%. The business had revenue of $2.39 billion for the quarter, compared to the consensus estimate of $2.36 billion. During the same period in the previous year, the firm earned $1.40 EPS. The company’s quarterly revenue was up 3.0% compared to the same quarter last year. Zoetis has set its FY 2026 guidance at 7.000-7.100 EPS. As a group, research analysts expect that Zoetis Inc. will post 6.07 earnings per share for the current year.

Zoetis Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 2nd. Investors of record on Monday, April 20th will be paid a $0.53 dividend. This represents a $2.12 dividend on an annualized basis and a yield of 1.8%. The ex-dividend date of this dividend is Monday, April 20th. Zoetis’s dividend payout ratio is presently 35.22%.

About Zoetis

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.